Search

everythinglearnresearchcommunity

for

Search:↓

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Ginsenoside F2 may help prevent hair loss and promote hair growth better than finasteride.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Sex-determining genes may affect male baldness.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Policosanol helps treat hair loss by balancing hormones and supporting hair growth.

Mesotherapy is more effective than topical spray for female hair loss treatment.

Increased cell death and reduced cell growth in hair follicles contribute to baldness.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

Advancements in hair biology include new treatments and tools for hair growth and alopecia.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Wnt signaling is crucial for skin and hair development and its disruption can cause skin tumors.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

Methyl vanillate spray increases hair count and hair mass in women with hair loss.

New treatments for hair loss may target specific pathways and generate new hair follicles.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Sex hormones, especially estradiol, can change chicken feather shapes and colors.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Sex steroids affect the MafB gene differently in male and female hamsters.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.